Current outlook of Biosimillar DevelopmentVeeda through its V-Konnect series interacted with Dr. Susobhan Das and discussed aboutFeb 21, 2022Feb 21, 2022
Veeda’s successful execution of a bioequivalence study involving ovarian cancer patientsIntroductionFeb 8, 2022Feb 8, 2022
India — An attractive hub for clinical researchAdvancement in medical sciences has benefited humanity in many ways. However, in the process of conducting clinical trials, incidences of…Jan 18, 2022Jan 18, 2022
Development and Execution of In Vivo BioassaysBioassays are involved in each stage of drug discovery, starting from Target Identification until discovering the Lead compound. Bioassays…Jan 17, 2022Jan 17, 2022
India — An attractive hub for clinical researchAdvancement in medical sciences has benefited humanity in many ways. However, in the process of conducting clinical trials, incidences of…Dec 8, 2021Dec 8, 2021
Parameters to Consider during preparation of Master Protocols for Oncology Drugs and BiologicsIn our last blog on Master protocols, we discussed the definition of master protocol, the types and advantages of using Master Protocol in…Nov 23, 2021Nov 23, 2021
A day in the life of a CRAHi, I am Gangichatti Laxman Kumar & I work as a Clinical Research Associate with Veeda and this is how a day in my life looks likeNov 19, 2021Nov 19, 2021
Veeda’s successful execution of a bioequivalence study involving ovarian cancer patientsIntroductionNov 18, 2021Nov 18, 2021
